急性淋巴细胞白血病与谱系不明急性白血病的单细胞分析:方法及分子见解
本文综述了用于急性淋巴细胞白血病(ALL)和谱系不明急性白血病的多种单细胞测序方法,包括RNA、DNA、染色质可及性和甲基化等单模态及多模态联合分析。文章重点阐述了这些方法在揭示ALL基因表达、细胞分化、克隆结构异质性以及白血病细胞与非白血病微环境动态相互作用中的应用,并讨论了单细胞测序在研究ALL生物学和治疗反应方面的潜在机遇与局限。
要点
- 单细胞测序可解析ALL的细胞起源、发育层级和个体发生。
- 多种单细胞技术可分析RNA、DNA、染色质可及性和甲基化等模态。
- 单细胞方法揭示ALL基因表达、分化和克隆结构的广泛异质性。
核心结论
- 单细胞测序方法有助于表征ALL生物学中细胞内在和外在特征,并揭示疾病发病机制和治疗耐药过程中的广泛异质性。
研究设计与样本
- 综述,检索范围未报告。
主要发现
- 单细胞测序可探索ALL的细胞起源、发育层级和个体发生以及驱动发病、进展和治疗反应的分子异质性。
- 存在多种针对特定模态的单细胞技术,包括RNA、DNA、染色质可及性和甲基化,以及不断扩展的多模态同时分析方法。
- 单细胞测序方法使得表征ALL生物学的细胞内在和外在特征成为可能。
局限性
- 原文讨论了单细胞测序用于研究ALL生物学和治疗反应的潜在局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite recent progress in identifying the genetic drivers of acute lymphoblastic leukemia (ALL), prognosis remains poor for those individuals who experience disease recurrence. Moreover, acute leukemias of ambiguous lineage lack a biologically informed framework to guide classification and therapy. These needs have driven the adoption of multiple complementary single-cell sequencing approaches to explore key issues in the biology of these leukemias, including cell of origin, developmental hierarchy and ontogeny, and the molecular heterogeneity driving pathogenesis, progression, and therapeutic responsiveness. There are multiple single-cell techniques for profiling a specific modality, including RNA, DNA, chromatin accessibility and methylation; and an expanding range of approaches for simultaneous analysis of multiple modalities. Single-cell sequencing approaches have also enabled characterization of cell-intrinsic and -extrinsic features of ALL biology. In this review we describe these approaches and highlight the extensive heterogeneity that underpins ALL gene expression, cellular differentiation, and clonal architecture throughout disease pathogenesis and treatment resistance. In addition, we discuss the importance of the dynamic interactions that occur between leukemia cells and the nonleukemia microenvironment. We discuss potential opportunities and limitations of single-cell sequencing for the study of ALL biology and treatment responsiveness.
引用
- Iacobucci I, Witkowski MT, Mullighan CG, et al. Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights. Blood. 2023. PMID: 35926109. doi:10.1182/blood.2022016954
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。